Lumos Pharma, Inc.(LUMO)

$4.34—

Chart

Lumos Pharma, Inc.(LUMO)

NASDAQ

$4.34—

Chart Studio

LUMO(LUMO)

LUMO

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Analyst Sentiment

Wall St. Consensus

Buy

7 analysts·Limited coverage

Score

4 Buy (57%)3 Hold (43%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

457%

Hold

343%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$7.00

+61.3%

Consensus

$16.50

+280.2%

Bull

$26.00

+499.1%

12-Month Target Range7 analysts

$7.00$16.50$26.00

Current $4.34Consensus

Current Price

$4.34

Upside to Consensus

$12.16

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+9679.81%

EPS—

FY2028

Rev-95.06%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E
Revenue Avg	$1M	$100M	$5M
Low	$1M	$100M	$5M
High	$1M	$100M	$5M
EBITDA Avg	$-1M	$-100M	$-5M
Low	$-1M	$-100M	$-5M
High	$-1M	$-100M	$-5M
EBIT Avg	$-1M	$-100M	$-5M
Low	$-1M	$-100M	$-5M
High	$-1M	$-100M	$-5M
Net Income Avg	$-14M	$-7M	$-6M
Low	$-17M	$-7M	$-6M
High	$-10M	$-7M	$-6M
EPS Avg	$-1.58	$-0.82	$-0.70
Low	$-2.14	$-0.82	$-0.70
High	$-1.28	$-0.82	$-0.70
Analysts (Rev / EPS)	3 / 3	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M
Low	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M
High	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M
EBITDA Avg	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-2M
Low	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-2M
High	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-2M
EBIT Avg	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-2M
Low	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-2M
High	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-1M	$-2M
Net Income Avg	$-2M	$-2M	$-2M	$-2M	$-2M	$-2M	$-1M	$-1M
Low	$-2M	$-2M	$-2M	$-2M	$-2M	$-2M	$-1M	$-1M
High	$-2M	$-2M	$-2M	$-2M	$-2M	$-2M	$-1M	$-1M
EPS Avg	$-0.23	$-0.26	$-0.20	$-0.19	$-0.21	$-0.23	$-0.17	$-0.16
Low	$-0.23	$-0.26	$-0.20	$-0.19	$-0.21	$-0.23	$-0.17	$-0.16
High	$-0.23	$-0.26	$-0.20	$-0.19	$-0.21	$-0.23	$-0.17	$-0.16
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Dec 8, 2022Jefferies

Jefferies Downgrades Lumos Pharma to Hold, Lowers Price Target to $7

Target:$7.00

+57.0%from $4.46

May 10, 2022Piper Sandler

Upcoming topline data could drive Lumos Pharma share gains, says Piper Sandler

Target:$26.00

+223.0%from $8.05

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance